Carole Johnston

Title: Carole Johnston: Innovator in Alzheimer's Research

Introduction

Carole Johnston is a notable inventor based in Oxford, GB. She has made significant contributions to the field of medical research, particularly in understanding the genetic factors associated with late-onset Alzheimer's disease. Her innovative work has the potential to impact the lives of many individuals at risk for this condition.

Latest Patents

Carole Johnston holds a patent for a method that determines the propensity for developing late-onset Alzheimer's disease. This method identifies the presence of specific genes, namely the butyrylcholinesterase K variant and apolipoprotein E4, which indicate a predisposition to the disease. Her patent is a crucial step in advancing the understanding of genetic influences on Alzheimer's.

Career Highlights

Throughout her career, Carole has been associated with Bristol-Myers Squibb Company, where she has utilized her expertise to further research in the pharmaceutical industry. Her work has been instrumental in developing strategies for early detection and intervention in Alzheimer's disease.

Collaborations

Carole Johnston has collaborated with esteemed colleagues such as Anthony David Smith and Donald J Lehmann. These partnerships have enriched her research and contributed to the advancement of knowledge in the field of Alzheimer's.

Conclusion

Carole Johnston's innovative approach to understanding Alzheimer's disease through genetic research exemplifies her commitment to improving healthcare outcomes. Her contributions are vital in the ongoing battle against this debilitating condition.